Statin therapy in cardiovascular diseases other than atherosclerosis

Dominique Beaudry, Kenneth E. Stone, Suzanne Wetherold, John Hemphill, John McClish, Robert J Chilton

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Statins are drugs that inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, thereby blocking the synthesis of cholesterol. Since being discovered in Japan in the mid 1970s, statins have been widely used to lower low-density lipoprotein cholesterol. However, analysis of cardiovascular research has revealed other important effects beyond changes in lipid parameters, referred to as pleiotropic effects. This paper focuses on the effects of statins as anti-ischemic agents with improvement in endothelial function, along with studies on valvular aortic stenosis, atrial fibrillation, heart failure, peripheral arterial disease, and cancer. As the evolution of statin research continues, there appear to be new potential benefits from statins to be found in many facets of cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)25-32
Number of pages8
JournalCurrent Atherosclerosis Reports
Volume9
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Atherosclerosis
Cardiovascular Diseases
Therapeutics
Peripheral Arterial Disease
Aortic Valve Stenosis
Research
LDL Cholesterol
Atrial Fibrillation
Japan
Oxidoreductases
Heart Failure
Cholesterol
Lipids
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Beaudry, D., Stone, K. E., Wetherold, S., Hemphill, J., McClish, J., & Chilton, R. J. (2007). Statin therapy in cardiovascular diseases other than atherosclerosis. Current Atherosclerosis Reports, 9(1), 25-32. https://doi.org/10.1007/BF02693937

Statin therapy in cardiovascular diseases other than atherosclerosis. / Beaudry, Dominique; Stone, Kenneth E.; Wetherold, Suzanne; Hemphill, John; McClish, John; Chilton, Robert J.

In: Current Atherosclerosis Reports, Vol. 9, No. 1, 01.2007, p. 25-32.

Research output: Contribution to journalArticle

Beaudry, D, Stone, KE, Wetherold, S, Hemphill, J, McClish, J & Chilton, RJ 2007, 'Statin therapy in cardiovascular diseases other than atherosclerosis', Current Atherosclerosis Reports, vol. 9, no. 1, pp. 25-32. https://doi.org/10.1007/BF02693937
Beaudry D, Stone KE, Wetherold S, Hemphill J, McClish J, Chilton RJ. Statin therapy in cardiovascular diseases other than atherosclerosis. Current Atherosclerosis Reports. 2007 Jan;9(1):25-32. https://doi.org/10.1007/BF02693937
Beaudry, Dominique ; Stone, Kenneth E. ; Wetherold, Suzanne ; Hemphill, John ; McClish, John ; Chilton, Robert J. / Statin therapy in cardiovascular diseases other than atherosclerosis. In: Current Atherosclerosis Reports. 2007 ; Vol. 9, No. 1. pp. 25-32.
@article{0fce4ade90194f5787885fb2f50552bc,
title = "Statin therapy in cardiovascular diseases other than atherosclerosis",
abstract = "Statins are drugs that inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, thereby blocking the synthesis of cholesterol. Since being discovered in Japan in the mid 1970s, statins have been widely used to lower low-density lipoprotein cholesterol. However, analysis of cardiovascular research has revealed other important effects beyond changes in lipid parameters, referred to as pleiotropic effects. This paper focuses on the effects of statins as anti-ischemic agents with improvement in endothelial function, along with studies on valvular aortic stenosis, atrial fibrillation, heart failure, peripheral arterial disease, and cancer. As the evolution of statin research continues, there appear to be new potential benefits from statins to be found in many facets of cardiovascular disease.",
author = "Dominique Beaudry and Stone, {Kenneth E.} and Suzanne Wetherold and John Hemphill and John McClish and Chilton, {Robert J}",
year = "2007",
month = "1",
doi = "10.1007/BF02693937",
language = "English (US)",
volume = "9",
pages = "25--32",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Statin therapy in cardiovascular diseases other than atherosclerosis

AU - Beaudry, Dominique

AU - Stone, Kenneth E.

AU - Wetherold, Suzanne

AU - Hemphill, John

AU - McClish, John

AU - Chilton, Robert J

PY - 2007/1

Y1 - 2007/1

N2 - Statins are drugs that inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, thereby blocking the synthesis of cholesterol. Since being discovered in Japan in the mid 1970s, statins have been widely used to lower low-density lipoprotein cholesterol. However, analysis of cardiovascular research has revealed other important effects beyond changes in lipid parameters, referred to as pleiotropic effects. This paper focuses on the effects of statins as anti-ischemic agents with improvement in endothelial function, along with studies on valvular aortic stenosis, atrial fibrillation, heart failure, peripheral arterial disease, and cancer. As the evolution of statin research continues, there appear to be new potential benefits from statins to be found in many facets of cardiovascular disease.

AB - Statins are drugs that inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, thereby blocking the synthesis of cholesterol. Since being discovered in Japan in the mid 1970s, statins have been widely used to lower low-density lipoprotein cholesterol. However, analysis of cardiovascular research has revealed other important effects beyond changes in lipid parameters, referred to as pleiotropic effects. This paper focuses on the effects of statins as anti-ischemic agents with improvement in endothelial function, along with studies on valvular aortic stenosis, atrial fibrillation, heart failure, peripheral arterial disease, and cancer. As the evolution of statin research continues, there appear to be new potential benefits from statins to be found in many facets of cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=33846126566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846126566&partnerID=8YFLogxK

U2 - 10.1007/BF02693937

DO - 10.1007/BF02693937

M3 - Article

C2 - 17228487

AN - SCOPUS:33846126566

VL - 9

SP - 25

EP - 32

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 1

ER -